These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 30353451)

  • 1. Acute cytomegalovirus infection associated with pulmonary embolism treated successfully with rivaroxaban: case report.
    de Almeida CMG; Maluf FC; Maluf FC; Gaburo N; Saraceni AF; de Almeida-Neto C
    J Thromb Thrombolysis; 2019 Jan; 47(1):162-164. PubMed ID: 30353451
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pulmonary Embolism in a Young Immunocompetent Adult Infected with Cytomegalovirus. Are Novel Oral Anticoagulants an Efficient Alternative?
    Bountouris I; Moris D; Tsilimigras DI; Laoutaris G; Kritikou G; Palla VV; Karaolanis G
    In Vivo; 2017; 31(6):1193-1195. PubMed ID: 29102945
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Heparin-induced Thrombocytopenia Presenting With Deep Venous Thrombosis and Pulmonary Embolism Successfully Treated With Rivaroxaban: Clinical Case Report and Review of Current Experiences.
    Samoš M; Bolek T; Ivanková J; Stančiaková L; Kovář F; Galajda P; Kubisz P; Staško J; Mokáň M
    J Cardiovasc Pharmacol; 2016 Nov; 68(5):391-394. PubMed ID: 27464495
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of Novel Oral Anticoagulant to Treat Pulmonary Thromboembolism in Patient with Ulcerative Colitis Superinfected Cytomegalovirus Colitis.
    Kim SH; Jang S; Sung Y; Park JK; Park Y; Yun J; Kang SB
    Korean J Gastroenterol; 2017 Jul; 70(1):44-49. PubMed ID: 28728316
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytomegalovirus-associated thrombosis.
    Neppelenbroek SIM; Rootjes PA; Boxhoorn L; Wagenaar JFP; Simsek S; Stam F
    Neth J Med; 2018 Jul; 76(5):251-254. PubMed ID: 30019682
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The use of rivaroxaban for the treatment of thrombotic complications in four dogs.
    Yang VK; Cunningham SM; Rush JE; de Laforcade A
    J Vet Emerg Crit Care (San Antonio); 2016 Sep; 26(5):729-36. PubMed ID: 26990131
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Practical management of rivaroxaban for the treatment of venous thromboembolism.
    Imberti D; Benedetti R
    Clin Appl Thromb Hemost; 2015 May; 21(4):309-18. PubMed ID: 24057396
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multiple thrombosis associated with Cytomegalovirus enterocolitis in an immunocompetent patient: a case report.
    Kamatani K; Kenzaka T; Sugimoto R; Kumabe A; Kitao A; Akita H
    BMC Infect Dis; 2021 Jun; 21(1):530. PubMed ID: 34090366
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Home treatment of patients with low-risk pulmonary embolism with the oral factor Xa inhibitor rivaroxaban. Rationale and design of the HoT-PE Trial.
    Barco S; Lankeit M; Binder H; Schellong S; Christ M; Beyer-Westendorf J; Duerschmied D; Bauersachs R; Empen K; Held M; Schwaiblmair M; Fonseca C; Jiménez D; Becattini C; Quitzau K; Konstantinides S
    Thromb Haemost; 2016 Jul; 116(1):191-7. PubMed ID: 27010343
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of rivaroxaban in sickle cell disease and venous thromboembolism: A case report.
    Rozi W; Ali EAH; Al-Mashdali AF; Abdelrazek M; Yassin MA
    Medicine (Baltimore); 2021 Dec; 100(51):e27988. PubMed ID: 34941038
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rivaroxaban for the treatment of venous thromboembolism. A "real-life" perspective in 103 patients.
    Jara-Palomares L; Sanchez-Oro-Gomez R; Elias-Hernandez T; Morillo-Guerrero R; Ferrer-Galvan M; Asensio-Cruz MI; Barrot-Cortes E; Otero-Candelera R
    Thromb Res; 2014 Sep; 134(3):617-21. PubMed ID: 25034320
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rivaroxaban for Treatment of Pulmonary Embolism While Receiving Electroconvulsive Therapy.
    Shao E; Moore R; Linnane J
    J ECT; 2017 Sep; 33(3):e25-e26. PubMed ID: 28198719
    [No Abstract]   [Full Text] [Related]  

  • 13. Acute pulmonary embolism treatment with rivaroxaban results in a shorter duration of hospitalisation compared to standard therapy: an academic centre experience.
    Paczyńska M; Kurnicka K; Lichodziejewska B; Goliszek S; Dzikowska-Diduch O; Sobieraj P; Burzyński Ł; Kostrubiec M; Pruszczyk P; Ciurzyński M
    Kardiol Pol; 2016; 74(7):650-6. PubMed ID: 26779849
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A treatment strategy using subcutaneous fondaparinux followed by oral rivaroxaban is effective for treating acute venous thromboembolism.
    Kabuki T; Nakanishi R; Hisatake S; Fujii T; Dobashi S; Wakakura S; Kiuchi S; Fujino T; Ikeda T
    J Cardiol; 2017 Aug; 70(2):163-168. PubMed ID: 27979674
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Direct factor Xa inhibitors (rivaroxaban and apixaban) versus enoxaparin for the prevention of venous thromboembolism after total knee replacement: A meta-analysis of 6 randomized clinical trials.
    Ma G; Zhang R; Wu X; Wang D; Ying K
    Thromb Res; 2015 May; 135(5):816-22. PubMed ID: 25728496
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safety and effectiveness of oral rivaroxaban versus standard anticoagulation for the treatment of symptomatic deep-vein thrombosis (XALIA): an international, prospective, non-interventional study.
    Ageno W; Mantovani LG; Haas S; Kreutz R; Monje D; Schneider J; van Eickels M; Gebel M; Zell E; Turpie AG
    Lancet Haematol; 2016 Jan; 3(1):e12-21. PubMed ID: 26765643
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Can rivaroxaban be a drug of choice for treating heparin-induced thrombocytopenia in a patient with pulmonary thromboembolism?
    Vavlukis M; Kotlar I; Taravari H; Poposka L; Kedev S
    Anatol J Cardiol; 2017 Jul; 18(1):77-79. PubMed ID: 28680014
    [No Abstract]   [Full Text] [Related]  

  • 18. Possible Rivaroxaban Failure during the Postpartum Period.
    Rudd KM; Winans AR; Panneerselvam N
    Pharmacotherapy; 2015 Nov; 35(11):e164-8. PubMed ID: 26598101
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Outcomes associated with observation status versus inpatient management of pulmonary embolism patients anticoagulated with rivaroxaban.
    Weeda ER; Wells PS; Peacock WF; Fermann GJ; Baugh CW; Ashton V; Crivera C; Wildgoose P; Schein JR; Coleman CI
    Int J Cardiol; 2016 Nov; 222():846-849. PubMed ID: 27522388
    [No Abstract]   [Full Text] [Related]  

  • 20. Pulmonary embolism and acute cytomegalovirus infection in an immunocompetent patient.
    Del Borgo C; Gianfreda R; Belvisi V; Citton R; Soscia F; Notarianni E; Tieghi T; Mastroianni CM
    Infez Med; 2010 Dec; 18(4):270-2. PubMed ID: 21196823
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.